June 17, 2021 –
A few minutes before the webinar begins, please join.
Dial-in US:+1 669 254 5252 or +1 646 828 7666 or +1 669 216 1590 or +1 551 285 1373
Webinar ID:160 782 6639
US: +16692545252,,1607826639#,,,,*183098# or +16468287666,,1607826639#,,,,*183098#
During this COCA Call, clinicians will learn about the Centers for Disease Control and Prevention’s new interim guidance which provides a framework for healthcare providers in their initial assessment, evaluation, management, and follow-up of persons with possible post-COVID conditions. Post-COVID conditions refer to the wide range of physical and mental health consequences experienced by some patients that are present four or more weeks after SARS-CoV-2 infection, including by patients who had initial mild or asymptomatic acute infection. Post-COVID conditions are still being characterized and include symptoms such as cognitive difficulties, fatigue, headache, dyspnea, and palpitations. Subject matter experts, physicians, and patient representatives from across the United States collaborated to develop the new guidance. Rapid recognition by healthcare providers of patients with post-COVID conditions and multidisciplinary care using the assessments and approaches described in this guidance could improve the wellbeing and treatment of people with post-COVID conditions.
Jennifer R. Chevinsky, MD, MPH, Epidemic Intelligence Service Officer, Post-COVID-19 Conditions Unit, COVID-19 Response, Centers for Disease Control and Prevention
Alex Vosooney, MD, Chair, Subcommittee on Clinical Recommendations and Policies, American Academy of Family Physicians
Michael Saag, MD, Professor of Medicine, Director, UAB Center for AIDS Research, University of Alabama Birmingham